Advertisement

Celluläre und humorale „Abwehr“-Systeme und -Reaktionen

  • E. Fritze
Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 9)

Zusammenfassung

„Krankheit“ ist als Begriff, als subjektives Erlebnis und objektives Ereignis kaum allgemeingültig zu definieren. Infektionskrankheiten werden durch Bakterien und andere Mikroben verursacht, die den Organismus „krank“ machen. Indessen können aber pathogene Organismen jeder Art — Bakterien, Pilze, Viren, Rickettsien, Protozoon usw. — in aktiver Form im Gewebe oder selbst im Blut eines empfänghchen Wirtes vorkommen, ohne daß Krankheitszeichen auftreten. Wirt und Parasit können sich ignorieren oder wenigstens tolerieren (41). Zur Manifestierung einer Infektion oder einer anderen Schädigung als Krankheit muß offenbar das Gleichgewicht zwischen Noxe und Organismus in besonderer Weise gestört, die Reaktionsart des Organismus spezifisch ausgeprägt sein.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Abramson, H. A.: The mechanism of the inflammatory process. III. Electrophoretic migration of inert particles and blood cehs in gelatin sols and gels with reference to leucocyte emigration through the capillary wall. J. Gen. Physiol. 11, 743 (1928).PubMedGoogle Scholar
  2. 2.
    Ahern, J. J., W. R. Barclay and R. H. Ebert: Modifications of the rabbit ear chamber technique. Science (Lancaster, Pa.) 110, 665 (1949).Google Scholar
  3. 3.
    Allison, F, jr., M. R. Smith and W. B. Wood jr.: Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J. of Exper. Med. 102, 655 (1955).Google Scholar
  4. 4.
    Allison, F. jr.,M.R. Smith and W.B. Wood jr.: Studies on the pathogenesis of acute inflammation. H. The action of cortisone on the inflammatory response to thermal injurv. J. of Exper. Med. 102, 669. (1955).Google Scholar
  5. 4a.
    Asteup, T., and P. M. Peemin: Fibrinokinase and fibrinolytic enzymes. Nature (London) 161, 689 (1948).Google Scholar
  6. 4b.
    Asteup, T., and P. M. Peemin: Fibrinolysis. Acta Haemat. 7, 271 (1952).Google Scholar
  7. 4c.
    Asteup, T., and P. M. Peemin: Fibrinolysis in the organism. Blood 11, 781 (1956).Google Scholar
  8. 5.
    Atkins, E., F. Allison jr., M. R. Smith and W. B. Wood jr.: Studies on the antipyretic action of cortisone in pyrogen-induced fever. J. of Exper. Med. 101, 353 (1955).Google Scholar
  9. 6.
    Atkins, E., F. Allison jr., M. R. Smith and W. B. Wood jr.: Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of tjrphoid vaccine. J. of Exper. Med. 101, 519 (1955).Google Scholar
  10. 7.
    Atkins, E., F. Allison jr., M. R. Smith and W. B. Wood jr and W. B. Wood jr..Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of tjrphoid vaccine. J. of Exper. Med. 102, 499 (1955).Google Scholar
  11. 8.
    Ashton, N., and C. Cook: In vivo observations of the effects of cortisone upon the blood vessels in rabbit ear chambers. Brit. J. Exper. Path. 33, 445 (1952).Google Scholar
  12. 9.
    Baer, B., and A. Adoef: lOinische und tierExperimentelle Untersuchungen über die Wirkung einiger moderner cytostatischer Substanzen auf die Phagocytosefähigkeit der Leukocyten. Klin. Wschr. 1954, 199.Google Scholar
  13. 10.
    Balch, H. H., and M. T. Spenges: Phagocytosis by human leucocytes. I. Effect of fibrin on phagocytosis of staphylococci and of encapsulated pneumococci by normal human leucocytes. J. Clin. Invest. 33, 1314 (1954).PubMedGoogle Scholar
  14. 11.
    Bammee, H.: Untersuchungen über die Wirkung von bakteriellen Lipopolysacchariden auf Nervenzellen. UV-Absorptionsmessungen an Zellen vom intakten und durchschnittenen Nervus hypoglossus von Kaninchen. Z. Exper. Med. 127, 90 (1956).Google Scholar
  15. 11a.
    IIa. Barlow, J. L., L. Levine and H. van Vunakis: Studies on the inactivation of phage by the properdin system. VI. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  16. 12.
    Beeson, P. B.: Tolerance to bacterial pyrogens. I. Factors influencing its development. II. Role of the reticulo-endothellal system. J. of Exper. Med. 86, 29, 39 (1947).Google Scholar
  17. 13.
    Bennett, I. L., and P. B. Beeson: The properties and biologic effects of bacterial pyrogens. Medicine (Baltimore) 29, 365 (1950).Google Scholar
  18. 14.
    Bennett, I. L., and P. B. Beeson.Studies on the pathogenesis of fever. I. The effect of injection of extracts and suspensions of uninfected rabbit tissues upon the body temperature of normal rabbits. J. of Exper. Med. 98, 477 (1953).Google Scholar
  19. 15.
    Bennett, I. L., and P. B. Beeson Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leucocytes and from the fluid of sterile exudates. J. of Exper. Med. 98, 493 (1953).Google Scholar
  20. 16.
    Bennett, I. L., and P. B. Beeson and L. E. Clijff: Influence of nitrogen mustard upon reactions to bacterial endotoxins: Shwartzman phenomenon and fever. Proc. Soc. Exper. Biol. a. Med. 81, 304 (1952).Google Scholar
  21. 17.
    Bennett, I. L., and P. B. Beeson Conference on Polysaccharides in Biology, AA Princeton 1956.Google Scholar
  22. 17a.
    Bennett, I. L. jr., R. R. Wagnee and V. S. Lequiee: The production of fever by influenzal viruses. II. Tolerance in rabbits to the pvrogenic effect of influenzal viruses. J. of Exper. Med. 90, 335 (1949).Google Scholar
  23. 18.
    Bergmann, H., G. Buschmann, P. Do being, E. Feitze u. F. Wendt: Der Einfluß bakterieUer P3?T0gene (Lipopolysaccharide) auf die Phagocytoseaktivität der Granulo- cyten und auf die elektrische Oberflächenladung menschlicher BlutZellen in vivo. Klin. Wschr. 1954, 500.Google Scholar
  24. 19.
    Berry, L. J., R. W. Staee and E. C. Hallee: The effect of surface active agents on phagocytosis. J. Bacter. 57, 603 (1949).Google Scholar
  25. 20.
    Beeey, J. L., and T. D. Spies: Phagocytosis. Medicine (Baltimore) 28, 239 (1949).Google Scholar
  26. 21.
    Beeey, J. L., and T. D. Spies Effect of components of the tricarboxyUc-acid cycle on bacterial infections. Ann. New York Acad. Sei. 66, 370 (1956).Google Scholar
  27. 22.
    Beetheong, M., and L. E. Cluff: Studies of the effect of bacterial endotoxins on rabbit leucocytes. I. Effect of intravenous injection of the substances with and without induction of the local Shwartzman reaction. J. of Exper. Med. 98, 331 (1953).Google Scholar
  28. 23.
    Betke, K., L. Bickhoff, M. Kammüllee u. F. Helpenstein: Cytologische Untersuchung der Lymphknotenreaktion nach Antigen- und Fremdkörperinjektion bei der weißen Maus. Klin. Wschr. 1955, 619.Google Scholar
  29. 24.
    Boyden, S. V.: Fixation of bacterial products by er5rfchrocytes in vivo and by leucocytes. Nature (London) 171, 402 (1953).Google Scholar
  30. 25.
    Böhmig, R.: Pathologie und Bakteriologie der sog. Herdinfektion. Z. Rheumaforsch. 15, 1 (1956).Google Scholar
  31. 26.
    Beandis, H.: III. Über die Promunität (Depressionsimmunität). Erg. Hyg. 28,141 (1954).Google Scholar
  32. 27.
    Beaude, A. I., F. J. Caeey, D. Sutheeland and M. Zalesky: Studies with radioactive endotoxin. I. The use of Cr51to label endotoxin of Escherichia coli. J. Clin. Invest. 34, 850 (1955).Google Scholar
  33. 28.
    Braude, A. I. and M. Zalesky: Studies with radioactiveendotoxin. il. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with lethal dosis of E. coli endotoxin labehed with radioactive sodium Chromate. J. Clin. Invest. 34, 858 (1955).PubMedGoogle Scholar
  34. 28a.
    Braude, A. I. and M. Zalesky J. Feltes and M. Brooks: Differences between the activities of mature granulocytes in leukemic and normal blood. J. Clin. Invest. 33, 1036 (1954).PubMedGoogle Scholar
  35. 29.
    Brato, W.: Cellular products affecting the estabhshment of bacteria of different virulence. Ann. New York Acad. Sci. 66, 348 (1956).Google Scholar
  36. 30.
    Braun, O. H., O. Lüderitz, E. Schäferu. O. Westphal: Serologische Eigenschaften von Lipopolysacchariden aus Dyspepsiecohbakterien. Z. Hyg. 142, 522 (1956).Google Scholar
  37. 30a.
    Brückel, K. W., u. W. Reicmele: Atmung und Glykolyse der Leukocyten. I. Mitteilung: Der Stoffwechsel menschhcher Leukocyten bei Gesunden und Kranken. Z. Vitamin-, Hormon- u. Fermentforsch. 8, 241 (1957).Google Scholar
  38. 31.
    Clark, P. F., L. S. McClung, H. Pinkerton, W. H. Price, H. A. Schneider and W. Träger: Influence of nutrition in experimental infection. Bacter. Rev. 13, 99 (1949).Google Scholar
  39. 32.
    Clufp, L. E.: Studies of the effect of bacterial endotoxins on rabbit leucocytes. II. Development of acquired resistance. J. of Exper. Med. 98, 349 (1953).Google Scholar
  40. 33.
    Coons, A. H., E. H. Leduc and J. M. Connolly: Leucocytes involved in antibody formation. Ann. New York Acad. Sci. 59, 951 (1955).Google Scholar
  41. 34.
    Coons, A. H., E. H. Leduc and J. M. Connolly Immunohistochemical studies of antibody response in the rabbit. Federat. Proc. 12, 439 (1953).Google Scholar
  42. 34a.
    Coons, A. H., E. H. Leduc and J. M. Connolly: Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J. of Exper. Med. 102, 49 (1955).Google Scholar
  43. 35.
    Cranston, W. I., F. Goodale jr., E. S. Snell and F. Wendt: The role of leucocytes in the initial action of bacterial pyrogens in man. Chn. Sci. 15, 219 (1956).Google Scholar
  44. 36.
    Crepea, S. B., G. E. Magnin and C. V. Sbastone: Effect of ACTH and cortisone on phagocytosis. Proc. Soc. Exper. Biol. a. Med. 77, 704 (1951).Google Scholar
  45. 37.
    Cronkite, E. P., and G. Brecher: The protective effect of granulocytes in radiation injury. Ann. New York Acad. Sci. 59, 815 (1955).Google Scholar
  46. 38.
    D’Antona, D.: Sort de la toxine diphthérique injectée dans le tissu souscutané du cobaye. Rév. d’Immunol. 3, 413 (1937).Google Scholar
  47. 39.
    Delaunay, A. La properdine et son importance en immunologie. Presse méd. 1956, 65.;Google Scholar
  48. 39a.
    D’Antona, D. et J. Pages: Le complément dans la physiologie du leucocyte. Rév. d’Immunol. 10, 33 (1946).Google Scholar
  49. 39b.
    D’Antona, D. La diapédèse leucocytaire, ses facteurs et son mécanisme. The mechanism of inflammation. Montreal: Acta. Inc. 1953.Google Scholar
  50. 40.
    Dougherty, T. F.: Studies of the antiphlogistic and antibody suppressing functions of the pituitary adrenocortical secretions. Ree. Progr. in Hormone Res. 7, 307 (1952).Google Scholar
  51. 41.
    Dubos, René J.: Biochemical determinants of infection. Bull. New York Acad. Med. 31, 5 (1955).Google Scholar
  52. 41a.
    Dubos, René J R. W. Schädler and D. Boeme: Effects of bacterial endotoxins on susceptibility to infection with gram-positive and acid-fast bacteria. Amer. Assoc. Immunologists, Chicago 1957.Google Scholar
  53. 41b.
    Dubos, René J Effect of metabohc factors on the susceptibilityofalbino mice to experimental tuberculosis. J. of Exper. Med. 101, 59 (1955).Google Scholar
  54. 42.
    Duchon, L.: Une preuve du rôle cellulaire dans l’étude du conflit ceUules-microorganismes. Indice d’activité cellulaire. Aim. Inst. Pasteur 82, 254 (1952).Google Scholar
  55. 42a.
    Duran-Reynals, F.: Tissue permeabihty and spreading factors in infection; contribution to host: parasite problem. Bacter. Rev. 6, 197 (1942).Google Scholar
  56. 43.
    Ebert, R. H., H. W. Florey and B. D. Pullinger: A modification of a Sandison-Clark chamber for observation of transparent tissue in the rabbits ear. J. of Path. 48, 79 (1939).Google Scholar
  57. 44.
    Ebert, R. H., H. W. Florey and B. D. Pullinger and: Changes in connective tissue reaction induced by cortisone. Ann. Int. Med. 37, 506 (1952).PubMedGoogle Scholar
  58. 45.
    J. J. Ahern and R. G. Bloch: Development of tuberculous infection. In vivo observations in the rabbit ear chamber. Proc. Soc. Exper. Biol. a. Med. 68, 625 (1948).Google Scholar
  59. 45a.
    Eger, W.: Pers. Mitt., unveröffenthcht.Google Scholar
  60. 45b.
    Eger, W.: Pers Beiträge zur Experimentellen Lebernekrose, zu ihrer Entstehung und ihrer Verhütung. Acta hepatol. 3, H. 3/4 (1955).Google Scholar
  61. 45c.
    Eger, W.: Pers Der Einfluß von Dextran und Zymosan auf die toxische Lebernekrose (Zur Frage der Wirkungsweise des Properdinsystems). Acta hepatol. 4, H. 5/6 (1956).Google Scholar
  62. 46.
    Ehrich, W. E.: Die zellulären Blldungsstätten der Antikörper. Klin. Wschr. 1955, 315.Google Scholar
  63. 47.
    Ehrich, W. E Dynamik der Reizbeantwortung. Verh. Dtsch. Ges. inn. Med. 62, 163 (1956).Google Scholar
  64. 48.
    T. N. Harris: Formation of antibodies in popliteal lymphnode in rabbits. J. of Exper. Med. 76, 335 (1942).Google Scholar
  65. 49.
    Ehrich, W. B and T. N. Harris: The site of antibody formation. Science (Lancaster, Pa.) 101, 28 (1945).Google Scholar
  66. 49a.
    Ehrich, W. B and T. N. Harris D. L. Drabkin and C. Forbian: Nucleic acids and the production of antibody by plasma cells. J. of Exper. Med. 90, 157 (1949).Google Scholar
  67. 50.
    Ehrich, W. B, and T. N. Harris Cellular sources of antibodies; in J. L. Tullís: Blood cells and plasma proteins. New York 1953.Google Scholar
  68. 50a.
    Ehrich, W. B and T. N. Harris Die Entzündung. Handbuch der allgemeinen Pathologie, Bd. VIl/1. Berlin, Göttingen, Heidelberg: Springer 1956.Google Scholar
  69. 51.
    Eichelberger, E., M. Schmidhauser-Kopp, H. Hurni, M. Friscay u. O. Westphal: Biologische Wirkungen eines hochgereinigten Pyrogens (Lipopolysaccharids) aus Salmonella abortus equi. Schweiz, med. Wschr. 1955, 1190; 1955, 1213.Google Scholar
  70. 52.
    Ehrich, W. B„ and T. N. Harris u. G. SCHÖNHOLZER: Fibrinolyse als Form der unspezifischen Reizbeantwortung. Verh. dtsch. Ges. inn. Med. 62, 200 (1956).Google Scholar
  71. 53.
    Ehrich, W. B„ and T. N. Harris u. H. Isliker: Das Verhalten des Properdins nach intravenöser Injektion bakterieller Lipopolysaccharide beim Menschen. Helvet. Physiol. Acta 14, C 64 (1956).Google Scholar
  72. 54.
    Ehrich, W. B„ and T. N. Harris Fibrinolyse nach intravenöser Injektion bakterieller Pyrogene. Acta neuro vegetativa (Wien) 11, 201 (1955).Google Scholar
  73. 55.
    Enders, J. F.: Antibodies in human gammaglobulin; in J. L. Tullís: Blood cells and plasma proteins. New York 1953.Google Scholar
  74. 55a.
    Essex, H. E., and A. Grana: Behavior of the leucocytes of the rabbit during periods of transient leucopenia variously induced. Amer. J. Physiol. 158, 396 (1949).PubMedGoogle Scholar
  75. 56.
    Eyquem, A., and J. Tullís: Die klinische Bedeutung des Properdins. VI. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  76. 57.
    Farr, R. S., S. L. Clark jr., I. E. Profitt and D. H. Campbell: Some humoral aspects of the development of tolerance to bacterial pyrogens in rabbits. Amer. J. Physiol. 177,269 (1954).PubMedGoogle Scholar
  77. 57a.
    Favez, G., F. Aguet et A. Bossy: La médication anti-inflammatoire non spécifique dans le traitement de la tuberculose pulmonaire évolutive. Hebr. med. Acta 21, 464 (1954).Google Scholar
  78. 58.
    Feldberg, W.: The role of mediators in the inflammatory tissue response. Int. Arch. Allergy 8,15 (1956)PubMedGoogle Scholar
  79. 59.
    Fine, J.: The effect of peripheral vascular collapse on the antibacterial defense mechanisms. Ann. New York Acad. Sci. 66, 329 (1956).Google Scholar
  80. 60.
    Fischel, E. E., E. A. Kabat, H. C. Stoerk, M. Skolnick and A. E. Bezer: Suppression by cortisone of granuloma formation and antibody in guinea pigs receiving egg albumin with Freund adjuvants. J. of Allergy 25, 195 (1954).Google Scholar
  81. 60a.
    Fischer, H., H. Brückner, W. Fritzsche u. H. Becker: Über das Verhalten von Fibrinolyse, Komplement- und Properdinaktivität bei der vegetativen Gesamtumschaltung. Verh. dtsch. Ges. inn. Med. 62, 323 (1956).Google Scholar
  82. 60b.
    Fischer, H., H. Brückner, W. Fritzsche u. H. Becker u. K. Röwe: Basische Polypeptide als,,endogene Antibiotica”, ihr Vorkommen und ihre Wirkungsweise. VI. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  83. 61.
    Fishman, M., and I. L. Shechmeister: The effect of ionizing radiation on phagocytosis and the bactericidal power of the blood. II. The effect of radiation on ingestion and digestion of bacteria. J. of Exper. Med. 101, 275 (1955).Google Scholar
  84. 62.
    Fleisher, G. A.: Peptidases in human leucocytes. Ann. New York Acad. Sci. 59, 1012 (1955).Google Scholar
  85. 63.
    Follette, J. H., W. N. Valentine, E. B. Hardin and J. S. Lawrence: Studies on the glucuronic acid content of human leucocytes in health and disease. J. Labor. Clin. Med. 43, 134 (1954).Google Scholar
  86. 63a.
    Franks, E., J. Fine and L. Pillemer: Serum properdin levels in hemorrhagic shock. Proc. Soc. Exper. Biol. a. Med. 89, 223 (1955).Google Scholar
  87. 64.
    Friscay, M., E. Eichenberger u. G. Schönholzer: Frühveränderungen in Niere und Milz nach ein- und zweimaliger intravenöser Injektion eines Endotoxins. Schweiz, med. Wschr. 1957, 631.Google Scholar
  88. 65.
    Fritze, E., P. Doering, H. Manecke u. R. Schoen: Oberflächenveränderungen der Blutzellen durch pyrogene Reizstoffe. Schweiz, med. Wschr. 1958, 783.Google Scholar
  89. 66.
    Fritze, E., P. Doering, H. Manecke u. R. Schoen Grenzflächenphänomene der BlutZellen din-ch pyrogene Reizstoffe. Verh. dtsch. Ges. inn. Med. 60, 939 (1954).Google Scholar
  90. 67.
    Fritze, E., P. Doering, H. Manecke u. R. Schoen u. F. Wendt: Zum Wirkungsmechanismus bakterieUer Lipopolysaccharide. I. Über einen sekundären endogenen Hasmafaktor mit Phagocytosewirkung. Klin. Wschr 1955, 523Google Scholar
  91. 68.
    Fritze, E., P. Doering, H. Manecke u. R. Schoen. Zum Wirkungsmechanismus bakterieller Lipopolysaccharide. II. Die Phagocytoseaktivität menschlicher Blutgranulocyten unter dem Einfluß bakterieUer Lipopolysaccharide in vitro. Klin. Wschr. 1955, 575.Google Scholar
  92. 69.
    Fritze, E., P. Doering, H. Manecke u. R. Schoen.Über den Emfluß von Heparin auf die neutrophilen Granulocyten. Klin. Wschr 1955, 719Google Scholar
  93. 70.
    Fritze, E.: Über die Regulation der Granulocytenfunktion durch zelleigene Faktoren. V. Kongreß d. Europ. Ges. f. Hämatologie 1955, 234.Google Scholar
  94. 70a.
    E.Fritze: Fritze, E u. H. WoRATZ: Unveröffentlicht.Google Scholar
  95. 71.
    Fritze, E Oberflächeneigenschaften der Blutzellen. Pflügers Arch. 257, 12 (1953).PubMedGoogle Scholar
  96. 72.
    E. Fritze: Fritze, E Das Abwehrsystem der neutrophilen Granulozjrten. Dtsch. med. Wschr. 1956, 601.Google Scholar
  97. 72a.
    Fritze, E Die Beantwortung bakterieUer Reize durch die neutrophilen Granulocyten. Verh. dtsch. Ges. inn. Med. 62, 204 (1956).Google Scholar
  98. 72b.
    — Unveröffenthcht.Google Scholar
  99. 72c.
    E.Fritze: Fritze, E u. H. H. Schneider: Zur Wirkung bakterieUer Pyrogene bei intravenöser und intrathekaler Injektion. (Im Druck.)Google Scholar
  100. 73.
    Fritzsche, W.: Das Verhalten des Properdin- und Komplementspiegels beim Experimentellen Peptonschock. 6. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  101. 74.
    Frobisher, M. jr., and E. I. Parsons: Resistance against toxigenic corynebacterium diphtheriae in rabbits foUowing injections of non-toxigenic diphtheria bacilli. Amer. J. Hyg. 37, 53 (1943).Google Scholar
  102. 75.
    Gerbrandy, J., W. I. Cranston and E. S. Snell: The initial process in the action of bacterial pyrogens in man. Chn. Sei. 13, 453 (1954).Google Scholar
  103. 75a.
    Ginsberg, H. S., and R. J. Wedgwood: Inactivation of virus by the properdin system. Ann. New York Acad. Sci. 66, 251 (1956).Google Scholar
  104. 76.
    Glick, D., and B. Sylven: Evidence for heparin nature of nonspecific hyaluronidase inhibitor on tissue extracts and blood serum. Science (Lancaster, Pa.) 113, 388 (1951).Google Scholar
  105. 77.
    Gölkel, A., u. K. Steindl: Über die Wirkung der Reizkörpertherapie auf die ACTH- Aktivität des menschhchen Blutes. Ärztl. Forsch. 5, 444 (1951).Google Scholar
  106. 77a.
    Gordon, A. S.: Some aspects of hormonal influences upon the leucocytes. Aim. New York Acad. Sci. 59, 907 (1955).Google Scholar
  107. 78.
    Graham, H. T., O. H. Lowry, N. Wahl and M. K. Priebat: Mast ceUs as sources of tissue histamine. J. of Eyper. Med. 102, 307 (1955).Google Scholar
  108. 78a.
    Grant, R., and W. J. Whalen: Latency of pyrogen fever. Appearence of a fast-acting pyrogen in the blood of febrile animals and in plasma incubated with bacterial pyrogen. Amer. J. Physiol. 173, 47 (1953).PubMedGoogle Scholar
  109. 79.
    Grant, R., and W. J. Whalen J. Lewis and J. Ahrne: Effects of intrahypothalamic injections of pyrogens. Federat Proc.. 14, 61 (1955).Google Scholar
  110. 80.
    Grant, R., and W. J. Whalen Refractoriness to pyrogens. Effects of incubation of pyrogenic with plasma from normal and refractory donors on the responses of refractory recipients. Amer. J. Physiol. 173,246 (1953).PubMedGoogle Scholar
  111. 80a.
    Gretjer, W.: Zur Bedeutung endogener proteolytischer Fermente. Verh. dtsch. Ges. inn. Med. 62, 344 (1956).Google Scholar
  112. 80b.
    Hahn, F. und A. Lange: Versuche zur Isoherung von Rattenserum-Anaphylatoxin. Arch. exp. Path. u. Pharmak. 227, 12 (1956).Google Scholar
  113. 80c.
    Hahn, F. und A. Lange und H. Giertz: Anaphylaktoide Reaktionen durch künsthche Blutersatzstoffe.Arch. exp. Path. u. Pharm. 222, 603 (1954).Google Scholar
  114. 80d.
    Hahn, F. und A. Lange und A. Oberdorf: Antihistaminica und anaphylaktoide Reaktionen. Z. f. Immun- forschg. 107, 528 (1950).Google Scholar
  115. 81.
    Harwerth, H.-G., u. F. Wöhler: Neuere Ergebnisse über Verteilung, Verhalten und Stoffwechselwirkungen von Phenylbutazon. IX. Internat. Rheumatol. Kongr. Toronto 1957.Google Scholar
  116. 81a.
    Hegemann, F.: Experimenteller Beitrag zum „Properdinproblem“. Verh. dtsch. Ges. inn. Med. 62, 327 (1956).Google Scholar
  117. 81b.
    Heilmeyer, L.: Die Klinik der Entzündungsreaktion und ihre Beeinflussung. Verh. dtsch. Ges. inn. Med. 62, 227 (1956).Google Scholar
  118. 82.
    Heilmeyer, I.: Fimktionsprüfung der Leukopoese des Knochenmarks. Dtsch. med. Wschr. 82, 644 (1957).PubMedGoogle Scholar
  119. 83.
    Hellerstein, S., D. E. Holtkamp, M. E. Hickey, R. M. Hill and A. R. Bfchanan: Effect of hypothalamic extrait on leukocytes of hifant rats. Amer. j. Physiol. 171, 106 (1952).PubMedGoogle Scholar
  120. 84.
    Hensler, L.: Nebenwirkungen der Pyrifertherapie. Mitteilung eines FaUes mit tödlicher Purpura. Schweiz, med. Wschr. 1953, 817.Google Scholar
  121. 85.
    Herbut, P. A., and W. H. Kraemer: The possible role of the properdin system in transplantable cancer. The effect of zymosan on transplantable human carcinoma. Cancer Res. 16, 1048 (1956).PubMedGoogle Scholar
  122. 86.
    Hinz, C. F. jr.: Properdm levels in infectious and noninfectious disease. Ann. New York Acad. Sei. 66, 268 (1956).Google Scholar
  123. 86a.
    Hinz, C. F. jr. S. Jordan jr., and L. Pillemer: The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 35, 453 (1956).PubMedGoogle Scholar
  124. 86b.
    Hansrz, C. F jr, J. Abbaham A. L. Pillemer: Requirement for properdin in hemolysis of human erythrocytes treated with tannic acid. Proc. Soc. Exper. Biol. a. Med. 94, 230 (1957).Google Scholar
  125. 87.
    Hansrz, C. F., J. Abbaham. A. L. Pillemer The effect of an antibody to properdin on hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria (PISTH). J. Clin. Invest. 36, 900 (1957).Google Scholar
  126. 88.
    Hinz, J. G: Phagocytin: A bactericidal substance from polymorphnuclear leucocjies. J. of Exper. Med. 103, 589 (1956).Google Scholar
  127. 89.
    Hinz, J. G. Studies of the bactericidal action of phagocytin. J. of Exper. Med. 103, 613 (1956).Google Scholar
  128. 89a.
    Hinz, J. G: Biochemical studies on the bactericidal power of phagocytic cells. Ann. New York Acad. Sei. 66, 382 (1956).Google Scholar
  129. 89b.
    Höbing, F. O.: Zoologische Symbioseforschung und medizinische Infektionslehre. Verh. dtsch. Ges. inn. Med. 63, 94 (1957).Google Scholar
  130. 90.
    Hörder, M. H., u. B. Kickhöpen: Vergleichende Untersuchungen über den Nachweis der Fibrinolyse nach Injektion eines bakteriellen Lipopolysaccharids (Pyrexal) Acta hämatol. (Basel) 17, 321 (1957).Google Scholar
  131. 90a.
    Hoff, F.: Khnische Probleme der vegetativen Regulation und der Neuraipathologie. Dtsch. med. Wschr. 1952, 65, 113, 146.Google Scholar
  132. 91.
    Hoff, F.: Die Bedeutung der regulationspathologischen Sicht für die Therapie. Verh. dtsch. Ges. inn. Med. 59, 122 (1953).Google Scholar
  133. 92.
    Hoff, F.: Bemerkungen zum Problem der unspezifischen Ab wehr Vorgänge. Verh. dtsch. Ges. inn. Med. 62, 209 (1956).Google Scholar
  134. 93.
    Horvath, G., G. Ludany u. J. Vajda: Die Wirkung von Cortison auf die Auswanderung der Leukocyten und ihre Bakterienphagocytose. Arch. Internat. Pharmacodynamic 1955, 357.Google Scholar
  135. 93a.
    Howard, J. G., D. Rowley and A. C. Wardlaw: Stimulation of non-specific immunity by the “Lipid A” component of bacterial lipopolysaccharide. Nature (London) 179, 314 (1957).Google Scholar
  136. 94.
    93a. Hurni, H.: Vortrag. 6. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  137. 95.
    Isliker, H. C.: Stand und Probleme der Erforschung des Properdinsystems. Verh. dtsch. Ges. inn. Med. 62, 197 (1956).Google Scholar
  138. 96.
    Isliker, H. C.:. The properdin system. Vox sanguinis 1, 8 (1956).Google Scholar
  139. 97.
    Jaeger, W.: Reizantworten am Auge nach intravenöser Injektion bakterieller Pyrogene. Verh. dtsch. Ges. inn. Med. 62, 338 (1956).Google Scholar
  140. 98.
    Jaeger, W. Experimentelle Untersuchungen über Fibrinolyse im Kammerwasser. Bericht 59. Dtsch. ophthalm. Ges. Heidelberg 1955.Google Scholar
  141. 98a.
    Janeway, Ch. A.: The nature of immune processes; in J. L. Tullís: Blood ceUs and plasma proteins. New York 1953.Google Scholar
  142. 99.
    Kaulla, K. N. v.: Autoaktivierungund Autofibrinolyse. Eine einfache SchneUmethode zur Gewinnung hochaktiven menschlichen fibrinolytischen Materials. Klin. Wschr. 1957, 667.Google Scholar
  143. 100.
    Kerby, G. P., and J. A. Barrett jr.: The effect of hydrocortisone and of piromen in vitro on leucocytes of patients receiving ACTH and cortisone therapy. J. Clin. Invest. 33, 725 (1954).PubMedGoogle Scholar
  144. 101.
    Kerby, G. P., and J. A. Barrett jr A method for detection of leucocyte injury based on release of a lysozymelike enzyme. Proc. Soc. Exper. Biol. a. Med. 81, 129 (1952).Google Scholar
  145. 102.
    Kerby, G. P., and J. A. Barrett jr Release of enzyme from human leucocytes on damage by bacterial derivatives. Proc. Soc. Exper. Biol. a. Med. 81, 381 (1952).Google Scholar
  146. 103.
    Kerby, G. P., and J. A. Barrett jr The occurrence of acid mucopolysaccharides in human leucocytes and urine. J. Clin. Invest. 34, 1738 (1955).PubMedGoogle Scholar
  147. 103a.
    Ketchel, M. M., and C. B. Favour: The influence of a plasma factor on in vitro leucocyte migration. Science (Lancaster, Pa.) 118, 79 (1953).Google Scholar
  148. 104.
    Ketchel, M. M., and C. B. Favour The acceleration and the inhibition of migration of human leucocytes in vitro by plasma protein fractions. J. of Exper. Med. 101, 647 (1955).Google Scholar
  149. 105.
    Kiser, J. S., H. Lindh and G. C. de Mello: The effect of various substances on resistance to experimental infections. Ann. New York Acad. Sci. 66, 312 (1956).Google Scholar
  150. 106.
    Koch, E.: Der Leukocytenabbau und seine Beeinflußbarkeit durch Steroidhormone. Fol. haemat. N. F. (Lpz.) 1, 160 (1956).Google Scholar
  151. 106a.
    Koch, E T. Horny-Kiewytsch u. H. St. Stender: Strahlendosis und Abbauzellen. Strahlenther. 100, 253 (1956).Google Scholar
  152. 107.
    kjröger, E.: Zur Antikörperbildung und Antikörperproduktion von pyrogenen Lipopolysacchariden aus gramnegativen Darmbakterien bei Kaninchen und Mensch. Klin. Wschr. 1957, 406.Google Scholar
  153. 108.
    Kuna, A., and R. Chambers: The effect of saccharides on leukocyte movement. J. Clin. Invest. 32, 436 (1953).PubMedGoogle Scholar
  154. 109.
    Landy, M.: Increase in resistance foUowing administration of bacterial lipopoly- saccharides. Ann. New York Acad. Sci. 66, 292 (1956).Google Scholar
  155. 109a.
    Land Y, M. and L. Pillemer: Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides. J. of Exper. Med. 103, 823 (1956).Google Scholar
  156. 109b.
    Land Y, M. and L. Pillemer Increased resistance to infection and accompanying alteration in properdin levels following administration of bacterial lipopolysaccharides. J. of Exper. Med. 104, 383 (1956).Google Scholar
  157. 110.
    Land Y, M. and L. Pillemer and M. J. Shear: Various host response to polysaccharides of mammahan and plant origin. 6. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  158. 111.
    Lanman, J. T., H. R. Biermann and L. R. Byron jr.: Transfusion of leucemic leucocytes. Blood 5, 1099 (1950).PubMedGoogle Scholar
  159. 111a.
    Leaky, R. H., and H. R. Morgan: The inhibition by cortisone of the cytotoxic activity of PPD on tubercuhn-hypersensitive cells in tissue culture. J. of Exper. Med. 96, 549 (1952).Google Scholar
  160. 112.
    Leduc, E. H., A. H. Coons and J. M. Connolly: Studies on antibody production. II- The primary and secondary responses in the pophteal Ijrmph node of the rabbit. J. of Exper. Med. 102, 61 (1955).Google Scholar
  161. 113.
    Leon, M. A.: Quantitative studies on the properdin-complement system. J. of Exper. Med. 103, 285 (1956).Google Scholar
  162. 114.
    Lewis, T.: The blood vessels of the human skin and their responses. London 1941.Google Scholar
  163. 115.
    Ludany, G., J. Vajda, G. Horvath u. E. Toth: Wirkung des Cortisons und des ACTH auf die Bakterienphagocytose der Leukocyten. Acta physiol. (Budapest) 7, 431 (1954).Google Scholar
  164. 115a.
    E. Tóth: Cortison und die Leukocytenphagocytose. Experientia (Basel) 9, 28 (1953).Google Scholar
  165. 116.
    Macfarlane, R. G. and R. Biggs: Fibrinolysis. Its mechanism and significance. Blood 3, 1167 (1948).PubMedGoogle Scholar
  166. 117.
    Marcus, St., D. W. Esplín and G. A. Hill: Effects of cortisone, ascorbic acid and piromen on phagocytosis in mice. Proc. Soc. Exper. Biol. a. Med. 84, 565 (1953).Google Scholar
  167. 118.
    McCutcheon, M.: Chemotaxis and locomotion of leukocytes. Ann. New York Acad. Sei. 59, 941 (1955).Google Scholar
  168. 119.
    McCutcheon, M. Chemotaxis in leukocytes. Physiologic. Rev. 26, 319 (1946).Google Scholar
  169. 120.
    McNall, E. G.: Assay of properdin in biological fluids. Proc. Soc. Exper. Biol. a. Med. 94, 399 (1957).Google Scholar
  170. 121.
    Martin, S. P., C. H. Pierce, G. Middlebrook and R. J. Dubos: The effect of tubercle bacilli on the polymorphonuclear leucocytes of normal animals. J. of Exper. Med. 91, 381 (1950).Google Scholar
  171. 122.
    G. R. McKinney and R. Green: The metabohsm of human polymorphonuclear leucocytes. Ann. New York Acad. Sci. 59, 996 (1955).Google Scholar
  172. 123.
    S. N. Chaudhuri, R. Green and G. R. McKinney: The effect of adrenal steroids on aerobic lactic acid formation in human leukocytes. J. Clin. Invest. 33, 358 (1954).PubMedGoogle Scholar
  173. 124.
    S. N. Chaudhuri, R. Green and G. R. McKinney The effect of bacterial products and hormones on human leucocytes.Clin. Res. Proc. 1, 47 (1953).Google Scholar
  174. 124a.
    S. N. Chaudhuri, R. Green and G. R. McKinney Effect of bacteria and their products on migration of leucocytes. Proc. Soc. Exper. Biol. a. Med. 81, 286 (1952).Google Scholar
  175. 124b.
    Martin, H.: Beeinflussung der Properdinaktivität durch Erythrocytenstromata. Verh. dtsch. Ges. inn. Med. 62, 331 (1956).Google Scholar
  176. 125.
    Martin, H.Properdin und Hämolyse. VI. Europ. Kongr. f. Hämatologie Kopenhagen 1957.Google Scholar
  177. 126.
    Meier, R., P. Desaulles u. B. Schär: Analyse der biochemischen Ursachen der entzündhchen Zellreaktion. Verh. naturforsch. Ges. Basel 67, 447 (1956).Google Scholar
  178. 127.
    Meier, R., P. Desaulles u. B. Schär Verschiedenartiger Wirkungstypus bakterieUer „entzündungserregender“ Substanzen und anderer „Reizstoffe“. Arch, exper. Path. u. Pharmakol. 224, 104 (1955).Google Scholar
  179. 128.
    Meier, R., P. Desaulles u. B. Schär u. B. Schär: Wirkung von Harnextraktstoffen auf die Bewegungsreaktionen der Leukocyten. Experientia (Basel) 7, 308 (1951).Google Scholar
  180. 129.
    Meier, R., P. Desaulles u. B. Schär.Leukocjrtenemigrationsförderung durch Antigen-Antikörper-Reaktion in vitro.Experientia (Basel) 11, 395 (1955).Google Scholar
  181. 130.
    Meier, R., P. Desaulles u. B. Schär.Spezifische Wirkung einiger tierischer und bakterieller Polysaccharide auf Leukocyten in vitro. Experientia (Basel) 10, 376 (1954).Google Scholar
  182. 131.
    Meier, R., P. Desaulles u. B. Schär Über den Einfluß entzündungserregender Einwirkungen auf Bewegung, Wachstum und Stoffwechsel isoherter Zellen und Gewebe. Beitrag zur Analyse der ceUulären Reaktionen beim EntzündungsVorgang. Z. exper. Med. 87, 283 (1933).Google Scholar
  183. 132.
    Meier, R., P. Desaulles u. B. Schär u. L. Neipp: Untersuchung der chemotherapeutischen Wirkung von Sulfonamiden durch zusätzliche Behandlung mit chemotaktisch wirkenden Polysacchariden aus Harn und Bakterien. Schweiz, med. Wschr. 1956, 249.Google Scholar
  184. 133.
    Menkin, V.: The leucopenic factor of exudates. The mechanism concerned in the leucopenia induced by it. Arch, of Path. 42, 154 (1946).Google Scholar
  185. 134.
    Menkin, V: Factors concerned in the mobihzation of leucocytes in inflammation. Ann. New York Acad. Sci. 59, 956 (1955).Google Scholar
  186. 135.
    Menkin, V Djmamics of inflammation. New York: Macmillan 1940.Google Scholar
  187. 136.
    Menkin, V Newer concepts of inflammation. Springfield (lllinois, USA): Ch. C. Thomas Puhl. 1950.Google Scholar
  188. 137.
    Menkin, V L’homéostase dans l’inflammation. Schweiz, med. Wschr. 1952, 1184.Google Scholar
  189. 138.
    Menkin, V Modern views on inflammation. Internat. Arch. Allergy a. Appl. Immunol. 4, 131 (1953).Google Scholar
  190. 138a.
    Menkin, V Leukopenia and inflammation. Arch, of Path. 41, 50 (1946).Google Scholar
  191. 139.
    Miescher, P.: Immunohämatologie der Thrombocyten und Leukocyten. Erg. inn. Med. N. F. 7, 170 (1956).Google Scholar
  192. 139a.
    Miles, A. A.: Concluding remarks (zu der Monographie: “natural resistance to infections”). Ann. New York Acad. Sci. 66, 410 (1956).Google Scholar
  193. 140.
    Miles, A. A. and J. S. F. Niven: The enhancement of infection during shock produced by bacterial toxins and other agents. Brit. J. Exper. Path. 31, 73 (1950).Google Scholar
  194. 141.
    Miller, C. P.: The effect of irradiation on natural resistance to infection. Ann. New York Acad. Sci. 66, 280 (1956).Google Scholar
  195. 141a.
    Mills, C. A.: Bone marrow nutrition in relation to the phagocytic activity of blood granulocytes. Blood 4, 150 (1949).PubMedGoogle Scholar
  196. 141b.
    Moeschlin, S., u. B. Debural: Antikörperbildung der PlasmaZellen in vitro. lffoin. Wschr. 1952, 827.Google Scholar
  197. 141c.
    Moeschlin, S., u. B. Debural J. R. Pelaez and F. Hugentobler: Experimental investigations of relationship between plasma cells and antibody formation (phase contrast microscope). Acta haemat. (Basel) 6, 321 (1951).Google Scholar
  198. 142.
    Recherches expérimentales concernant les relations entre les cellules plasmatiques et la formation des anticorps (microscopic à contraste de phases). C. r. 3e Congr. Soc. Europ. d’Hématol. Rome 1951, p. 192.Google Scholar
  199. 143.
    Moon, V. H., and G. A. Tershakovec: Effects of cortisone on blood cells after thermal stress. Proc. Soc. Exper. Biol. a. Med. 85, 7 (1954).Google Scholar
  200. 144.
    Moon, V. H., and G. A. Tershakovec. Effects of cortisone upon local capillary permeability. Proc. Soc. Exper. Biol. a. Med. 85, 600 (1954).Google Scholar
  201. 145.
    C. G. Grand and G. A. Tershakovec: Dynamics of inflammation and of repair. Arch, of Path. 57, 44 (1954).Google Scholar
  202. 146.
    C. G. Grand and G. A. Tershakovec and G. A. Tershakovec: Dynamics of inflammation and of repair. Arch, of Path. 58, 285 (1954).Google Scholar
  203. 147.
    Mfdd, S., M. McCutcheon and B. Lucké: Phagocytosis. Physiologic. Rev. 14, 210 (1934).Google Scholar
  204. 147a.
    Myrvik, Q. N.: Serum bactericidins active against grampositive bacteria. Ann. New York Acad. Sei. 66, 391 (1956).Google Scholar
  205. 148.
    Nelson, R. A.: An alternative hypothesis for the,,properdin system“. IV. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  206. 149.
    Neter, E., O. Westphal, O. Lüderitz and E. A. Gorzynski: The bacterial hemagglutination test for the demonstration of antibodies to enterobacteriaceae. Ann. New York Acad. Sci. 66, 141 (1956).Google Scholar
  207. 150.
    E. A. Gorzynski, R. M. Gino, O. Westphal and O. Lüderitz: The enterobacterial hemagglutination test and its diagnostic potentialities. Canad. J. Microbiol. 2, 232 (1956).Google Scholar
  208. 151.
    O. Westphal, O. Lüderitz, E. A. Gorzynski and E. Eichenberger: Studies of enterobacterial lipopolysaccharides. J. of Immunol. 76, 377 (1956).Google Scholar
  209. 152.
    Nungester, W. J., and A. M. Ames: The relationship between ascorbic acid and phagocytic activity. J. Inf. Dis. 83, 50 (1948).Google Scholar
  210. 153.
    Nungester, W. J., and A. M. Ames Mechanisms of man’s resistance to infectious diseases. Bacter. Rev. 15, 117 (1951).Google Scholar
  211. 154.
    Nungester, W. J., and A. M. Ames and A. M. Ames: Effect of selected chemical substances on phagocytosis. J. Inf. Dis. 90, 51 (1952).Google Scholar
  212. 155.
    Nungester, W. J., and A. M. Ames and W. Lanning: Electrophoresis studies of leucocytes and bacteria in relation to the mechanisms of phagocjrbosis. J. Inf. Dis. 90, 61 (1952).Google Scholar
  213. 156.
    Oakley, C. L., J. Batty and G. H. Warrack: Local production of antibodies. J. of Path. 63, 33 (1951).Google Scholar
  214. 156a.
    Osgood, E., A. Seaman, H. Tivey and D. A. Rigas: Duration of life and different stages of maturation of normal and leukemic leucocytes. V. Congrès internat. d’Hématologie, Paris 1954.Google Scholar
  215. 157.
    Palm, J. E.: Proc. Amer. Assoc. Cancer Res. 2, 138 (1957); zit. (225a).Google Scholar
  216. 158.
    Pillemer, L., L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd and A. C. Wardlaw: The properdin system and immunity: I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science (Lancaster, Pa.) 120, 279 (1954).Google Scholar
  217. 159.
    Pillemer, L., L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd and A. C. Wardlaw Ergebnisse d. inn. Medizin, K. F. Bd. 9 19Google Scholar
  218. 159a.
    Pillemer L., M. D. Schoenberg, L. Blum and L. Würz: Properdin system and immunity: II. Interaction of ttie properdin system witli polysaccharides. Science (Lancaster, Pa.) 122, 545 (1955).Google Scholar
  219. 159b.
    L. Blum, I. H. Lepow, L. Wurz and E. W. Todd: The properdin system and immunity: III. The zymosan assay of properdin. J. of Exper. Med. 103, 1 (1956).Google Scholar
  220. 160.
    M. Landy and M. J. Shear: The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides. J. of Exper. Med. 106, 99 (1957).Google Scholar
  221. 161.
    C. F. Hinz jr. and L. Wurz: Preparation and properties of antihuman properdin rabbit serum. Science (Lancaster, Pa.) 125, 1244 (1957).Google Scholar
  222. 161a.
    Pillemer, L. and O. A. Ross: Alterations in serum properdin levels foUowing injection of zymosan. Science (Lancaster, Pa.) 121, 732 (1955).Google Scholar
  223. 162.
    Pillemer, L. and O. A. Ross The nature of the properdin system and its interactions with polysaccharide complexes. Ann. New York Acad. Sci. 66, 233 (1956).Google Scholar
  224. 163.
    Raffel, S.: Immunity, hypersensitivity, serology. New York: Appleton-Century Crofts, Inc. 1953.Google Scholar
  225. 163a.
    Rebuck, j. W., and R. C. Mellinger: Interruption by topical cortisone of leucocytic cycles in acute inflammation in man. Ann. New York Acad. Sci. 56, 715 (1953).Google Scholar
  226. 164.
    Rebuck, J. W., and R. C. Mellinger and J. H. Crowley: A method of studying leukocytic functions in vivo. Ann. New York Acad. Sci. 59, 757 (1955).Google Scholar
  227. 164a.
    Remy, D.: Über Eigenschaften leukaemischer Blutzellen. Ärztl. Forschg. 11, 1,330 (1957).Google Scholar
  228. 164b.
    Richter, K. M.: Studies on leucocytic secretory activity. Ann. New York Acad. Sci. 59, 863 (1955).Google Scholar
  229. 164c.
    Riley, J. F.: The relationship of the tissue mast cells to the blood vessels in the rat. J. of Path. 65, 561 (1953).Google Scholar
  230. 164d.
    Riley, J. F.: The effects of histamine-liberators on the mast cells of the rat. J. of Path. 65, 471 (1953).Google Scholar
  231. 165.
    Riley, J. F. and G. B. West: Histamine in tissue mast cells. J. of Physiol. 117, 72 (1952).Google Scholar
  232. 165a.
    Riley, J. F. and G. B. West :The presence of histamine in tissue mast cells. J. of Physiol. 120, 528 (1953).Google Scholar
  233. 165b.
    Robineaux, R.: Mouvements ceUulaires et fonction phagocytaire des granulocytes neutrophiles. Etude dynamique de la phagocytose bactérienne, virale, minérale et cellulaire. Rév. d’Hématol. 9, 364 (1954).Google Scholar
  234. 165c.
    Rochaesilva, M.: Antihistamine agents in aUergy; role played by leucocytes and platelets in anaphylactic and peptone shock. Ann. New York Acad. Sci. 50,1045 (1950).Google Scholar
  235. 165d.
    Riley, J. F.Concerning the mechanism of anaphylaxis and allergy. Brit. Med. J. 1952, 779.Google Scholar
  236. 165e.
    Riley, J. F.O. Bier and M. Aronson: Histamine release by anaphylatoxin. Nature (London) 168, 465 (1951).Google Scholar
  237. 166.
    Riley, J. F. Activation by polysaccharides of a histamine liberator (anaphylatoxin) in blood plasma. In “The mechanism of inflammation”. Montreal, Acta Inc. 1953.Google Scholar
  238. 167.
    Riley, J. F.Histamine. Its role in anaphylaxis and allergy. Springfield, Ill.: 1955. Ch. C. Thomas.Google Scholar
  239. 167a.
    Rohr, K.: Die komplementär-polare Wirkungsweise des myeloischen und lymphatischen Blutbildungsorgans. Acta haematol. (Basel) 18, 1 (1957).Google Scholar
  240. 168.
    Ross, O. A., A. R. Moritz, C. J. Walker, L. Würz, E. W. Todd and L. Pillemer: Role of the properdin system in whole body irradiation. Federat. Proc. 14, 418 (1955).Google Scholar
  241. 169.
    Ross, O. A., A. R. Moritz, C. J. Walker, L. Würz, E. W. Todd and L. Pillemer The properdin system in relation to fatal bacteremia foUowing total-body irradiation of laboratory animals. Ann. New York Acad. Sci. 66, 274 (1956).Google Scholar
  242. 169a.
    Rowley, D.: Stimulation of natural immunity to Escherichia Coli infections. Observations in mice. Lancet 1955 I 232.Google Scholar
  243. 170.
    Rowley, D Some factors affecting the resistance of animals to bacterial infection. Ann. New York Acad. Sci. 66, 304 (1956).Google Scholar
  244. 171.
    Rowley, D The basis for lipopolysaccharide induce non-specific immunity. VI. Europ. Kongr. f. Hämatologie, Kopenhagen 1957.Google Scholar
  245. 172.
    Sabin, F. R.: Cellular reactions to a dye-protein with a concept of the mechanism of antibody formation. J. of Exper. Med. 70, 67 (1939).Google Scholar
  246. 173.
    Sandison, I. C.: A new method for the microscopic study of living growing tissues by the introduction of a transparent chamber in the rabbit’s ear. Anat. Ree. 28, 281 (1924).Google Scholar
  247. 173a.
    Seabra, P.: Oxidase and lipase of the leukocyte. Ann. New York Acad. Sci. 59, 1022 (1955).Google Scholar
  248. 173b.
    Schär, B., u. R. Meier: Chemotaxine und Kapillarpermeabihtät. Experientia (Basel) 11, 272 (1955).Google Scholar
  249. 174.
    Schär, B., u. R. Meier F. W. Kahnt u. G. Huber: Zum Wirkungsmechanismus der Leukocytenemigration. Helv. physiol. acta 15, 116 (1957).Google Scholar
  250. 174a.
    Schmidt, A.: Die Bildung der Antikörper und ihre Bedeutung für Infektion und Immunität. Verh. dtsch. Ges. inn. Med. 58, 8 (1952).Google Scholar
  251. 174b.
    Schneider, H. A.: Nutrition of the host and natural resistance to infection. J. of Exper. Med. 87, 103 (1948).Google Scholar
  252. 174c.
    Schneider, H. A. and N. D. Zinder: Nutrition of the host and natural resistance to infection. J. of Exper. Med. 103, 207 (1956).Google Scholar
  253. 175.
    Schumacher, G.: KJinische und Experimentelle Untersuchungen über Verhalten und Funktion der Alpha-2- Globuhne. Verh. dtsch. Ges. inn. Med. 62, 347 (1956).Google Scholar
  254. 175a.
    Schumacher, G.Pers. Mitt., unveröffenthchtGoogle Scholar
  255. 175b.
    Selye, H.: On the mechanism through which hydro cortisone affects the resistance of tissues to injury. An experimental study with the granuloma pouch technique. J. Amer. Med. Assoc. 152, 1207 (1953).Google Scholar
  256. 176.
    Schumacher, G.Der heutige Stand der Stress-Konzeption. Münch, med. Wschr. 1953, 426.Google Scholar
  257. 177.
    Schumacher, G.Stress and the general adaptation syndrom. Brit. Med. J. 1950, 1383.Google Scholar
  258. 177a.
    Senda, N.: Movement of leucocyte. Rév. d’Hématol. 9, 418 (1954).Google Scholar
  259. 177b.
    Shapiro, R., B. Taylor and M. Taubenhaus: Local effects of cortisone on granulation tissue and the role of denervation and ischemia. Proc. Soc. Exper. Biol. a. Med. 76, 854 (1951).Google Scholar
  260. 178.
    Shear, M. J.: Reactions of mice with primary subcutaneous tumor to injection of a hemorrhage-producing bacterial polysaccharide. J. Nat. Cancer Inst. 4, 461 (1943/44).Google Scholar
  261. 179.
    Shechmeister, I. L., and M. Fishman: The effect of ionizing radiation on phagocjrtosis and thé bactericidal power of the blood. 1. The effect of radiation on migration of leucocytes. J. of. Exper. Med. 101, 259 (1955).Google Scholar
  262. 180.
    Siedek, H., u. H. Ph. Häusler: Über die Wirkungsweise von Pyrogenen. Dtsch. med. Wschr. 1955, 1128.Google Scholar
  263. 180a.
    Sieracki, J. C.: The neutrophilic leucocjrte. Ann. New York Acad. Sci. 59, 690 (1955).Google Scholar
  264. 180b.
    Silvermann, D.: A chemotropic substance derived from normal tissues. Arch, of Path. 25, 40 (1938).Google Scholar
  265. 180c.
    Smith, R. T., A. J. Braude and F. J. Carey: The distribution of Cr15labeled E. coli endotoxin in the generahzed Shwartzman reaction. J. Clin. Invest. 36, 695 (1957).PubMedGoogle Scholar
  266. 180d.
    Smith, M. R., and W. B. Wood jr.: Relation of surface phagocytosis to the fibrinous character of acute bacterial exudates. Science (Lancaster, Pa.) 110, 187 (1949).Google Scholar
  267. 181.
    Smith, J.M., and R. J. Dubos: The effect of nutritional disturbances on the susceptibility of mice to staphylococcal infections. J. of Exper. Med. 103, 119 (1956).Google Scholar
  268. 182.
    Soulier, J. P.: Variations pathologiques du complément et de la properdine. 6. Europ. Kongr. f. Haematologie, Kopenhagen 1957.Google Scholar
  269. 182a.
    Southam, C. M., and L. Pillemer: Im Druck, zit. (225a).Google Scholar
  270. 182b.
    Southam, C. M., and L. Pillemer A. E. Moore and C. P. Rhoads: Science (Lancaster, Pa.) 125,158 (1957)Google Scholar
  271. 183.
    Spector, V. G.: The role of some higher peptides in inflammation. J. of Path. 63, 93 (1951).Google Scholar
  272. 184.
    Speers, R. S.: Physiological approaches to an understanding of the function of eosinophUs and basophils. Ann. New York Acad. Sci. 59, 706 (1955).Google Scholar
  273. 185.
    Staudinger, H J. u. H. Kersten: Biochemische Untersuchungen zur Butazolidin- wirkung. IX. Internat. Rheumatol. Kongr. Toronto 1957.Google Scholar
  274. 186.
    Stamm, H., u. H. Triebold: Phenylbutazon und Stress. Schweiz. med.Wschr. 1957,766.Google Scholar
  275. 187.
    Stoerk, H. C.: Depression by cortisone of inherited and acquired resistance to infection and to tumor grafting: The effect of ACTH and cortisone upon infection and resistance edit, by G. Shwartzman, Columbia Univ. Press 1953.Google Scholar
  276. 188.
    Surgenor, D. M., B. Alexander, R. Goldstein and K. Schmid: A system for the separation of the protein components of human plasma. H. The components of the clotting process. J. Phys. a. Colloid Chem. 55, 94 (1951).Google Scholar
  277. 189.
    Sundberg, D.: Lymphocytes and plasma cells. Ann. New York Acad. Sci. 59, 671 (1955).Google Scholar
  278. 190.
    Szent-Györgyi, A.: The mechanism of inflammation. Montreal, Acta Inc., Med. Puhl. 1953 (G. Jasmin and A. Robert, editors).Google Scholar
  279. 191.
    Taliaferro, W. H., and L. G. Taliaferro: Effect of X-rays on immunity. A review. J. of Immun. 66, 181 (1951).Google Scholar
  280. 192.
    Taliaferro, W. H., and L. G. Taliaferro The cellular basis of immunity. Aimual. Rev. Microbiol. 3, 159 (1949).Google Scholar
  281. 193.
    Taubenhaus, M., and G. D. Amromin: The effects of the hypophysis, thyroid, sex- steroids and the adrenal cortex upon granulation tissue. J. Labor, a. Clin. Med. 36,7 (1950).Google Scholar
  282. 194.
    Tausk, M.: Cortison, ACTH und Entzündung, ein endokrinologisches Problem. Schweiz, med. Wschr. 1954, 193.Google Scholar
  283. 195.
    Thomas, L.: Cortisone and infection. Ann. New York Acad. Sci. 56, 799 (1953).Google Scholar
  284. 195a.
    Thomas, L Infectious diseases. The effects of cortisone and adrenocorticotropic hormone on infection. Annual. Rev. Med. 3, 1 (1952).Google Scholar
  285. 196.
    Thomas, L J. Brunson and R. T. Smith: Studies on the generalised Shwartzman reaction. VI. Production of the reaction by the synergistic action of endotoxin with three synthetic acidic polymers. J. of Exper. Med. 102, 249 (1955).Google Scholar
  286. 197.
    Thomas, L., R. T. Smith and R. v. Korff: Studies on the generalised Shwartzman reaction. VII. The role of fibrinogen in the deposition of fibrinoid after combined injections of endotoxin and synthetic acidic polymer. J. of Exper. Med. 102, 263 (1955).Google Scholar
  287. 198.
    Timiras, P. S.: Phagocytosis and the hypophysis-adrenocortical system. Acta endocrinol. (Copenh.) Suppl. 11 (1953).Google Scholar
  288. 199.
    Tischendorf, W., u. E. Fritze: Zur Aggregationsneigung der Leukocjrten. Klin. Wschr. 1949, 170.Google Scholar
  289. 200.
    Todd, J. P.: Bacterial pyrogens. J. Pharm. Pharmacol. 7, 625 (1955).PubMedGoogle Scholar
  290. 201.
    Tompkins, E. H.: The monocyte. Ann. New York Acad. Sci. 59, 732 (1955).Google Scholar
  291. 202.
    Tonutti, E.: Hormone und örtliche Reizbeantwortung. Verh. dtsch. Ges. inn. Med. 62, 177 (1956).Google Scholar
  292. 203.
    Tullís, J. L.: Blood cells and plasma proteins. Acad. Press Inc. New York 1953.Google Scholar
  293. 204.
    Tullís, J. L. and D. M. Surgenor: Phagocytosis-promoting factor of plasma and serum. Ann. New York Acad. Sci. 66, 382 (1956).Google Scholar
  294. 205.
    Umbreit, W. W.: The influence of adrenalectomy and cortisone treatment on certain encymatic reactions in the rat: The effect of ACTH and cortisone upon infection and resistance, edit, by G. Shwartzman, Columbia Univ. Press 1953.Google Scholar
  295. 206.
    Tullís, J. L.Mechanisms of antibacterial action. Annual. Rev. Microbiol. 8, 167 (1954).Google Scholar
  296. 207.
    Ungar, G.: The fibrinolytic system and inflammation. Rev. Canad. Biol. 12, 253 (1953).PubMedGoogle Scholar
  297. 207a.
    Ungar, G.Inflammation and its control; a biochemical approach. Lancet 1952, 742;Google Scholar
  298. 207b.
    Ungar, G.Biochemical mechanism of the allergic reaction. Int. Arch. AUergy 4, 258 (1953).Google Scholar
  299. 208.
    E. Damgaard and F. P. Hümmel: Activation of Profibrinolysin by antigen-antibody reaction and by anaphylactoid agents; its relations to complement. J. of Exper. Med. 98, 291 (1953).Google Scholar
  300. 209.
    E. Damgaard and F. P. Hümmel.Action of salicylates and related drugs on inflammation. Amer. J. Physiol.171, 545 (1952).PubMedGoogle Scholar
  301. 210.
    E. Damgaard and F. P. Hümmel and S. H. Mist: Observations on the release of serum fibrinolysin by spezific antigen, peptone, and certain polysaccharides. J. of Exper. Med. 90, 39 (1949).Google Scholar
  302. 211.
    E. Damgaard and F. P. Hümmel and E. Damgaard: Tissue reactions to anaphylactic and anaphylactoid stimuli; proteolysis and release of histamine and heparin. J. of Exper. Med. 101, 1 (1955).Google Scholar
  303. 212.
    Valentine, W. N.: The enzymes of leukocytes. Ann. New York Acad. Sei. 59, 1003 (1955).Google Scholar
  304. 213.
    Valentine, W. N.J. H. Follette and J. S. Lawrence: The glycogen content of human leukocytes in health and disease. J. Clin. Invest. 32, 251 (1953).PubMedGoogle Scholar
  305. 214.
    Valentine, W. N.M. L. Pearce and J. S. Lawrence: Studies on the histamine content of blood, with special reference to leukemia, leukemoid reactions and leukocytosis. Blood 5, 623 (1950).PubMedGoogle Scholar
  306. 215.
    Valentine, W. N. and W. S. Beck: Biochemical studies on leukoc3rbes. I. Phosphatase activity in health, leukocytosis and myelocytic leukemia. J. Labor, a. Clin. Med. 38, 39 (1951).Google Scholar
  307. 215a.
    Valentine, W. N.J. H. Follette, E. B. Hardin, W. S. Beck and J. S. Lawrence: Studies on leukocyte alkaline phosphatase activity. Relation to “stress” and pituitary-adrenal activity. J. Labor, a. Clin. Med. 44, 219 (1954).Google Scholar
  308. 216.
    Wachstein, M.: Alkaline phosphatase activity in blood and bone marrow cells. J. Labor, a. Clin. Med. 31, 1 (1946).Google Scholar
  309. 217.
    Valentine, W. N. Histochemistry of leukocytes. Ann. New York Acad. Sci. 59, 1052 (1955).Google Scholar
  310. 218.
    Wachstein, M Reduction of potassium tellurite by living tissues. Proc. Soc. Exper. Biol. a. Med. 72, 175 (1949).Google Scholar
  311. 219.
    Wagner, R. R., I. L. Bennett jr. and V. S. LeQuire: The production of fever by influenzal viruses. I. Factors influencing the febrile response to single injections of virus. J. of Exper. Med. 90, 321 (1949).Google Scholar
  312. 220.
    Wagner, R. R., I. L. Bennett jr. and V. S. LeQuire and I. L. Bennett jr.: The production of fever by influenzal viruses. III. Effect of receptor-destroying substances. J. of Exper. Med. 91, 135 (1950).Google Scholar
  313. 220a.
    Wardlaw, A. C., and L. Pillemer: The demonstration of the bactericidal activity of the properdin system. Ann. New York Acad. Sci. 66, 244 (1956).Google Scholar
  314. 221.
    Wagner, R. R., I. L. Bennett jr. and V. S. LeQuire L. Blum and L. Pillemer: Bactericidal activity of the properdin system in human serum. Federat. Proc. 14, 480 (1955).Google Scholar
  315. 222.
    Wagner, R. R., I. L. Bennett jr. and V. S. LeQuire L. Blum and L. Pillemer and L. Pillemer: The properdin system and immunity. V. The bactericidal activity of the properdin system. J. of Exper. Med. 103, 553 (1956).Google Scholar
  316. 222a.
    Wedgwood, R. J., H. S. Ginsberg and L. Pillemer: The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J. of Exper. Med. 104, 707 (1956).Google Scholar
  317. 223.
    Wedgwood, R. J., H. S. Ginsberg and L. Pillemer and L. Pillemer: The kinetics of the bactericidal activity of the properdin system. Ann. New York Acad. Sei. 66, 247 (1956).Google Scholar
  318. 224.
    Wedgwood, R. J., H. S. Ginsberg and L. Pillemer Inhibition of the bactericidal activity of the properdin system with specific bacterial antibodies. J. Clin. Invest. 36, 935 (1957).Google Scholar
  319. 225.
    Weissbecker, L.: Allgemeine Corticosteroidtherapie und ihre Durchführung bei endo- crinen Störungen und Infektionskrankheiten. Verh. dtsch. Ges. inn. Med. 62, 251(1956).Google Scholar
  320. 225a.
    Wendt, F., W. J. Cranston, F. Goodale jr. and E. S. Snell: Zur Toleranzentwicklung nach Pyrogeninjektion. Quantitative Bewertung der Fieberreaktion. Verh. dtsch. Ges. inn. Med. 62, 334 (1956).Google Scholar
  321. 226.
    Wendt, F., W. J. Cranston, F. Goodale jr. and E. S. Snell u. E. Fritze: Unveröffenthcht.Google Scholar
  322. 226a.
    Werthemann, A.: Die Ab Wehrkräfte des menschhchen Körpers und die Möghchkeit der therapeutischen Beeinflussung. Leipzig 1934.Google Scholar
  323. 227.
    Westphal, O., O. Lüderitz, B. Elickhöfen, E. Eichenberger u. W. Keiderling: Exogene und endogene Reizstoffe. The mecanism of inflammation. Montreal, Acta Inc. 1953.Google Scholar
  324. 228.
    Westphal, O., O. Lüderitz, B. Elickhöfen, E. Eichenberger u. W. Keiderling u. B. Kickhöfen: Über endogene Reizstoffe. Beitrag zur Analyse von Reizwirkungen und Entzündungsvorgängen. Z. Rheumaforsch. 12, 321 (1953).PubMedGoogle Scholar
  325. 229.
    Westphal, O., O. Lüderitz, B. Elickhöfen, E. Eichenberger u. W. Keiderling Properdin. Fortbildg. prakt. Med. Meran 1957.Google Scholar
  326. 230.
    Westphal, O., O. Lüderitz, B. ELickhöfen, E. Eichenberger u. W. Keiderling Hochgereinigte Reizstoffe und Prinzipien ihrer Wirkungsanalyse. Verh. dtsch. Ges. inn. Med. 62, 192 (1956).Google Scholar
  327. 230a.
    Westphal, O., O. Lüderitz, B. ELickhöfen, E. Eichenberger u. W. Keiderling Immunchemie; in Physiologische Chemie, herausgeg. v. B. Flaschenträger und E. Lehnartz. Springer-Verl. Berhn-Göttingen-Heidelberg 1957Google Scholar
  328. 230b.
    O. Lüderitz, E. Eichenberger u. E. Neter: Chemische Wirkgruppen in bak- terieUen Lipopolysaccharid-Reizstoffen. Dtsch. Z. Verdauungs- u. Stoffwechselkxkh. 15, 170 (1955).Google Scholar
  329. 231.
    Wettstein, A.: Chemie und Biologie neuer Corticoide. Verh. dtsch. Ges. inn. Med. 62, 214 (1956).Google Scholar
  330. 232.
    Wexler, B. C., and E. Tryczynski: Effect of bacterial polysaccharide (piromen) in preventing tissue loss in rabbits due to gangrene induced by jfrostbite. J. Labor, a. Clin. Med. 45, 296 (1955).Google Scholar
  331. 233.
    Wexler, B. C., and E. Tryczynski Cartilaginous deposits induced by freezing resolved by a bacterial polysaccharide (piromen). J. Labor, a. Clin. Med. 47, 706 (1956).Google Scholar
  332. 233a.
    White, R. G., A. H. Coons and J. M. Connolly: Studies on antibody production. III. The alum granuloma. J. of exper. Med. 102, 73 (1955).Google Scholar
  333. 234.
    White, R. G., A. H. Coons and J. M. Connolly. Studies on antibody production. IV. The role of a wax fraction of myco- bacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumm. J. of Exper. Med. 102, 83 (1955).Google Scholar
  334. 235.
    Wilson, A. T.: The egestion of phagocytised particles by leucocjrtes. J. of Exper. Med. 98, 305 (1953).Google Scholar
  335. 236.
    Windle, W. F., W. W. Chambers, W. A. Ricker, L. G. Ginger and H. Koenig: Reaction of tissues to administration of a pjnrogenic preparation from a Pseudomonas species. Amer. J. Med. Sei. 219, 422 (1950).Google Scholar
  336. 237.
    Wood, W. B. jr., and M. R. Smith: An experimental analysis of the curative action of peniciUin in acute bacterial infections. I. The relationship of bacterial growth rates to the antimicrobial effect of penicillin. H. The role of phagocytic cells in the process of recovery. HI. The effect of suppuration upon the antimicrobial action of the drug. J. of Exper. Med. 103, 487, 499, 509 (1956).Google Scholar
  337. 238.
    Wood, W. B. jr., and M. R. Smith The inhibition of surface phagocytosis by the capsular „slime layer“ of pneu-mococcus type III. J. of. Exper. Med. 90, 85 (1949).Google Scholar
  338. 239.
    Wood, W. B. jr., and M. R. Smith The pathogenesis of fever. Amer. J. Med. 18, 351 (1955).Google Scholar
  339. 240.
    Wood, W. B. jr., and M. R. Smith Studies on the ceUular immunology of acute bacterial infections. Harvey Lect. Series XI, VII (1951—1952). Academic Press Inc., Puhl., New York 10, N. Y.Google Scholar
  340. 241.
    Wright, C.-S., and M. C. Dodd: Phagocytosis. Ann. New York Acad. Sei. 59, 945 (1955).Google Scholar
  341. 242.
    Wood, W. B. jr., and M. R. Smith W. E. Haines and Q. van Winkle: Microelectrophoretic studies of the normal and modified erythrocytes; zit. (236), unveröffenthcht.Google Scholar
  342. 238.
    Wood, W. B. jr., and M. R. Smith and C. A. Doan: A discussion of certain aspects of the cellular and humoral defense mechanism; in J. L. Tullís: Blood cells and plasma proteins. New York 1953.Google Scholar
  343. 239.
    Zarafonetis, C., D. R. Harmon and P. F. Clark: Influence of temperature upon opsonization and phagocytosis. J. Bacter. 53, 343 (1947).Google Scholar
  344. 240.
    Zweifach, W. B.: An analysis of the inflammatory reaction through the response of the terminal vascular bed to micro-trauma. The mechanism of inflammation. Montreal, Acta Inc. 1953.Google Scholar
  345. 241.
    Wood, W. B. jr., and M. R. Smith and R. Chambers: The action of hyaluronidase extracts on the capiUary waU. Ann. New York Acad. Sci. 52, 1047 (1950).Google Scholar
  346. 242.
    Wood, W. B. jr., and M. R. Smith E. Shorr and M. M. Black: The influence of the adrenal cortex on the behavior of the terminal vascular bed. Ann. New York Acad. Sci. 56, 626 (1953).Google Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1958

Authors and Affiliations

  • E. Fritze

There are no affiliations available

Personalised recommendations